Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
September 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 |
Press releases published on August 14, 2025
Applications for SBC First Pitch 2025, in presented by @Soft2Bet Invest is Now Open
EIN Presswire
·
August 14, 2025
LISBON, PORTUGAL, August 15, 2025 /EINPresswire.com/ -- SBC First Pitch 2025 is providing a platform to ambitious start-ups in the betting and igaming space in association with @Soft2Bet Invest. The event will showcase 30000+ industry professionals and …
6 Weeks to Go & SPiCE Central Asia 2025’s Top Speaker Sets the Stage for Transformation
EIN Presswire
·
August 14, 2025
TASHKENT, UZBEKISTAN, August 15, 2025 /EINPresswire.com/ -- There are officially only 6 weeks left until the inaugural SPiCE Central Asia 2025 – the premier summit for stakeholders tracking one of today’s most intriguing gaming markets! Join us in …
Grow London, London Stock Exchange & The Global City partner with London FinTech Summit to join global finance capitals
EIN Presswire
·
August 14, 2025
LONDON, UNITED KINGDOM, August 14, 2025 /EINPresswire.com/ -- London FinTech Summit, part of Fintech Week London, has announced strategic partnerships with Grow London (London …
SiGMA Euro-Med 2025 launches with exclusive affiliate retreat in Gozo
EIN Presswire
·
August 14, 2025
GOZO, MALTA, August 14, 2025 /EINPresswire.com/ -- In the lead-up to SiGMA Euro-Med 2025, SiGMA Group is extending an exclusive invitation to 50 VIP affiliates for an unforgettable networking retreat in Gozo, Malta’s sister island. Powered by the …
Professional.me Raises $3.1M to Power the Future of Hiring with Micro-LLMs for Employers and Professionals
EIN Presswire
·
August 14, 2025
Professional.me announces $3.1M seed round led by Raha Beach Ventures, bringing total funding to $4.6M to transform how companies hire and manage talent. ABU DHABI, ABU DHABI, UNITED ARAB EMIRATES, August 14, 2025 /EINPresswire.com/ -- While traditional …
AppTech Payments Corp. Highlights Q2 2025 Financial and Strategic Developments
GlobeNewswire
·
August 14, 2025
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AppTech Payments Corp. (“AppTech” or the “Company”) (NASDAQ: APCX), a fintech company innovating payment solutions for businesses, today announced financial results for the second quarter ended June 30, …
VERSES Announces Filing of Quarterly Report on Form 10-Q
GlobeNewswire
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES" or the "Company"), a cognitive computing company pioneering next-generation agentic software systems today announced that it has filed its …
Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH
GlobeNewswire
·
August 14, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
Digi Power X Reports Solid Mid-Year Financial Position, Removal of ‘Going Concern’ Risk and Positive Adjusted EBITDA in Q2 2025
GlobeNewswire
·
August 14, 2025
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“ …
YXT.com to Announce Financial Results for the First Six Months of 2025 on August 20, 2025
GlobeNewswire
·
August 14, 2025
SUZHOU, China, Aug. 14, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions in China, today announced that it plans to report its financial results …
INVO Fertility Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
GlobeNewswire
·
August 14, 2025
COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “ …
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
GlobeNewswire
·
August 14, 2025
AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis …
BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025
GlobeNewswire
·
August 14, 2025
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ended June 30, 2025 on Thursday, August 21, 2025 after market …
Emerita Resources Announces Concurrent Offering
GlobeNewswire
·
August 14, 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (“Emerita” …
CELOXFI Implements Military-Grade Security Protocols, Achieves 100% User Asset Insurance Coverage
GlobeNewswire
·
August 14, 2025
GOLDEN, CO , Aug. 14, 2025 (GLOBE NEWSWIRE) -- Celoxfi, the AI-powered crypto asset exchange, today announced a landmark upgrade to its security infrastructure, setting a new industry benchmark for user protection. The platform has secured 100% insurance …
Veea Inc. Announces Closing of $9.2 Million Public Offering
GlobeNewswire
·
August 14, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Veea Inc. (NASDAQ: VEEA) (“Veea” or the “Company”), a leader in intelligent edge infrastructure, announced the closing of its public offering of an aggregate of 9,189,096 shares of common stock and warrants to …
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
GlobeNewswire
·
August 14, 2025
BOSTON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, …
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
August 14, 2025
PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-year Invivyd’s target of near-term profitability (1H 2025) was not met but remains possible with the upcoming respiratory virus season …
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19
GlobeNewswire
·
August 14, 2025
Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, double-blind, placebo-controlled trial with a primary endpoint of reduction in symptomatic COVID-19, resembling …